Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

Belgium

Az Sint-Jan Brugge - Oostende Av, Bruges

Institut Jules Bordet, Brussels

Chu de Liege, Liège

Chu Ucl Namur - Site Godinne, Yvoir

France

Aphp - Hopital Henri Mondor, Créteil